Funding Announcements

"As a firm, Proskauer has been deeply involved with ProVision since we first became aware of its transformative capabilities, especially for side letter management. Having helped the team develop its current product offering and now working closely with the firm to help build some game-changing future features we are thrilled ILS has secured this important investment, which will help revolutionize our product offering to clients."

"Rebranding to Clarity is about exactly that, bringing more clarity to customer experience. We want AI to be simple, useful, and safe. A lot of tools in the market cut corners, and that doesn’t work in industries where mistakes aren’t an option. From day one we built Clarity to be compliant, secure, and easy to roll out. This new funding lets us keep improving the tech and building the right partnerships so companies can finally modernize customer operations with confidence."

"SSV’s support comes at a pivotal time as we deepen our enterprise service management practice. Their backing empowers us to extend our consulting teams, refine our delivery methodologies, and engage with major public- and private-sector organizations across the US and EMEA."

"I've had a good relationship with Jonny for a long time, working with him right through youth and senior levels with the Scotland team and then into management and coaching. The demand on players has never been greater and the margins of winning are finer than they have ever been, which only makes products like ScribePro more important. Technology like this can make things better for everyone involved in sport. From my experience as a player when I had some injury problems myself I know the process of sharing or even accessing fitness and injury data could be clunky, to say the least. And I'm looking forward to helping develop the platform further, supporting the decisions managers make with players and working with clinicians on recovery programmes and availability."

"We’re entering a transformative period for Adtec Healthcare. This investment from AIPO Fund and SG Biomedical not only provides the capital we need to expand globally but also reflects shared confidence in our vision: to make Cold Plasma a globally recognised and adopted standard in infection control and wound care. We’re proud of what our team has built, and excited to move forward with strong, experienced partners by our side."